Net profit of Godavari Drugs declined 1.30% to Rs 0.76 crore in the quarter ended December 2025 as against Rs 0.77 crore during the previous quarter ended December 2024. Sales declined 24.94% to Rs 22.18 crore in the quarter ended December 2025 as against Rs 29.55 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales22.1829.55 -25 OPM %11.148.70 - PBDT1.381.56 -12 PBT0.770.92 -16 NP0.760.77 -1 Powered by Capital Market - Live News

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News

Godavari Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 12 February 2026.Powered by Capital Market - Live News

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 15 January 2026.Powered by Capital Market - Live News

Net profit of Godavari Drugs declined 8.26% to Rs 1.00 crore in the quarter ended September 2025 as against Rs 1.09 crore during the previous quarter ended September 2024. Sales rose 2.15% to Rs 26.65 crore in the quarter ended September 2025 as against Rs 26.09 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales26.6526.09 2 OPM %7.4711.12 - PBDT1.721.83 -6 PBT1.121.25 -10 NP1.001.09 -8 Powered by Capital Market - Live News